ahlam1399
06-29-2016, 03:00 PM
FDA names Pazdur head of new Oncology Center of Excellence
WASHINGTON (Reuters) – The U.S. Food and Drug Administration’s high-profile cancer drug director, Dr. Richard Pazdur, has been named head of a newly created Oncology Center of Excellence that will coordinate the review of all the agency’s cancer therapeutics.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=UHjFs_9ek20:2qn3qUPq5Xo:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=UHjFs_9ek20:2qn3qUPq5Xo:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=UHjFs_9ek20:2qn3qUPq5Xo:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=UHjFs_9ek20:2qn3qUPq5Xo:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=UHjFs_9ek20:2qn3qUPq5Xo:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/UHjFs_9ek20
WASHINGTON (Reuters) – The U.S. Food and Drug Administration’s high-profile cancer drug director, Dr. Richard Pazdur, has been named head of a newly created Oncology Center of Excellence that will coordinate the review of all the agency’s cancer therapeutics.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=UHjFs_9ek20:2qn3qUPq5Xo:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=UHjFs_9ek20:2qn3qUPq5Xo:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=UHjFs_9ek20:2qn3qUPq5Xo:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=UHjFs_9ek20:2qn3qUPq5Xo:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=UHjFs_9ek20:2qn3qUPq5Xo:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/UHjFs_9ek20